Lunch with the Investigators: Hepatobiliary Cancers

Characterizing the Epidemiologic and Molecular Characteristics of Biliary Tract CancersПодробнее

Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers...Подробнее

Pancreas and Hepatobiliary | 2023 Best of GI Cancer ConferenceПодробнее

Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers...Подробнее

Hepatobiliary CancersПодробнее

Integrating New Research Information into Current Clinical Care — Hepatobiliary CancersПодробнее

Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers...Подробнее

Disaggregation of Hepatobiliary Cancer Mortality in Asian AmericansПодробнее

Master Protocols from a Regulatory Perspective - Margit Horiba, FDA (D3P16)Подробнее

Dr. Anton Bilchik Discusses: Gastrointestinal And Hepatobiliary Tumors: What you need to know.Подробнее

Luncheon with the Experts: Jonathan Strosberg, MDПодробнее

Hepatobiliary & Pancreatic Cancer Care | Fox Chase Cancer CenterПодробнее

Medical Minute - Hepatobiliary CancersПодробнее

Meet Dr. Jon Cardinal - Hepatobiliary Surgical Cancer CareПодробнее

Get To Know Cholangiocarcinoma with Dr. JavleПодробнее

Speaker Series Seminar: Dr. Xuehong ZhangПодробнее